Also trades as: GN.CO (CPH) · $vol 9M · GNNDY (OTC) · $vol 0M

$15.31

+0.00 (+0.00%)

OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 52 · $2.2B mcap · 127M float · 0.0001% daily turnover · Short 100% of daily vol

Revenue

$16.8B -6.4% ▼

5Y CAGR: +4.6%

Gross Profit

$8.1B -15.1% ▼

5Y CAGR: +2.2%

Operating Income

$1.8B -2.7% ▼

5Y CAGR: +2.1%

Net Income

$652M -34.1% ▼

5Y CAGR: -12.2%

EPS (Diluted)

$4.47 -34.1% ▼

5Y CAGR: -14.2%

EBITDA

$2.8B -10.3% ▼

5Y CAGR: +0.6%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$15.8B	$18.7B	$18.1B	$18.0B	$16.8B
YoY Growth	+17.3%	+18.5%	-3.0%	-0.7%	-6.4%
Cost of Revenue	$7.1B	$9.6B	$9.1B	$8.4B	$8.7B
Gross Profit	$8.7B	$9.1B	$9.0B	$9.6B	$8.1B
Gross Margin	55.0%	48.9%	49.9%	53.2%	48.2%
R&D Expenses	$1.4B	$1.4B	$1.5B	$1.5B	$837M
SG&A Expenses	$4.7B	$6.2B	$5.8B	$2.4B	$5.5B
Operating Expenses	$6.3B	$8.0B	$8.2B	$7.7B	$6.3B
Operating Income	$2.4B	$1.1B	$869M	$1.9B	$1.8B
Operating Margin	15.2%	5.9%	4.8%	10.3%	10.7%
Interest Expense	$91M	$186M	$326M	$379M	$644M
Income Before Tax	$2.3B	$725M	$343M	$1.4B	$912M
Tax Expense	$481M	$155M	$77M	$302M	$204M
Net Income	$1.8B	$511M	$228M	$988M	$652M
Net Margin	11.1%	2.7%	1.3%	5.5%	3.9%
EPS (Diluted)	$13.49	$3.99	$1.64	$6.78	$4.47
EBITDA	$3.5B	$2.4B	$2.4B	$3.1B	$2.8B
Shares Outstanding	130M	128M	139M	146M	146M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$4.2B	$5.0B	$4.0B	$4.2B	$4.0B	$4.7B	$2.1B	$2.2B
Cost of Revenue	$1.9B	$2.3B	$1.8B	$1.8B	$1.9B	$2.2B	$2.2B	$1.1B
Gross Profit	$2.3B	$2.7B	$2.2B	$2.3B	$2.1B	$2.5B	-$66M	$1.1B
Gross Margin	54.8%	53.2%	54.9%	55.6%	52.1%	53.4%	-3.2%	49.5%
R&D Expenses	$343M	$355M	$373M	$344M	$317M	$424M	$115M	$219M
SG&A Expenses	$1.4B	-$1.9B	$1.5B	$1.4B	$1.4B	-$2.0B	$792M	$868M
Operating Expenses	$1.8B	$2.1B	$2.0B	$1.9B	$1.7B	$1.9B	$406M	$1.1B
Operating Income	$516M	$601M	$215M	$460M	$331M	$565M	-$472M	-$16M
Operating Margin	12.4%	12.0%	5.4%	11.1%	8.4%	12.1%	-22.5%	-0.7%
Interest Expense	$145M	$87M	$228M	$297M	$254M	$295M	$188M	$285M
Income Before Tax	$371M	$503M	$114M	$232M	$118M	$449M	-$562M	-$280M
Tax Expense	$82M	$111M	$25M	$52M	$27M	$100M	-$124M	-$63M
Net Income	$271M	$367M	$71M	$165M	$73M	$343M	-$956M	-$22M
Net Margin	6.5%	7.3%	1.8%	4.0%	1.8%	7.3%	-45.6%	-1.0%
EPS (Diluted)	$1.86	$2.52	$0.49	$1.13	$0.50	$2.36	$-6.56	$-0.15
EBITDA	$774M	$875M	$681M	$807M	$713M	$1.0B	$1.1B	$235M
Shares Outstanding	146M	146M	146M	146M	146M	146M	146M	146M

GGNDF OTC